Dates: 24-25 May 2018
Venue: Cambridge, UK
Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 are part of Select Biosciences Innovations in Drug Discovery 2018 Conference Series to be held in Cambridge, UK.
This conference held co-located and concurrently with High-Content & Phenotypic Screening 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.
Stem Cells in Drug Discovery 2018: Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.
Antibodies in Drug Discovery 2018: The focus is to explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research. If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders, whilst networking with the technology providers.
Follow the link below for more information: